Vancouver, British Columbia--(Newsfile Corp. - November 27, 2018) - Alliance Growers Corp. (CSE: ACG) (FSE: 1LA) (WKN:
A2DFYX) (OTCQB: ALGWF) ("Alliance" or "the Company") is pleased to announce that it has received approval from the OTC Markets
Group to be listed on the OTCQB Venture Market as of November 27, 2018, under the OTCQB ticker symbol ALGWF.
Dennis Petke, CEO of Alliance Growers, stated: "We are pleased to be listed on the OTCQB, as this provides an opportunity to
attract a broader base of US and international investors with a transparent trading platform that will help to maximize the
Company's share value for its shareholders. It is well known that a great number of US investors would like to invest in publicly
traded Canadian cannabis stocks, such as Alliance Growers, but are unable to do so through their US brokers unless the Canadian
company is dual listed in the US. Admission to the OTCQB exchange is part of our long-term strategy to introduce the company to a
wide range of institutional and retail investors in the US. With the OTCQB dual listing Alliance is now able to access a new
investor base that is ten times that of Canada. This times well with our current financing initiatives and expansion of our
Canadian and international opportunities in the rapidly growing Cannabis sector."
The OTCQB is recognized as an established public financial market and is a leading market for international companies including
resource companies in the exploration and development stage. The OTCQB Venture Market offers companies the opportunity to build
their visibility, expand their liquidity and diversify their shareholder base on an established, public market without the rigid
procedures common with other US exchange listings. Their premium markets offer companies at all stages of development the right
platform to create a transparent trading experience for their investors. The OTCQB Venture Market quality standards provide a
strong baseline for transparency, as well as the technology and regulation to improve the information and trading experience for
investors.
Qualifying for listing on the OTCQB is a significant stepping stone for Alliance Growers. While Alliance Growers currently
trades on the Canadian Securities Exchange (CSE: ACG), its new secondary OTCQB listing provides better access to institutional
investors and a broader shareholder base. The OTCQB provides solutions to better engage and inform US investors about Alliance
Growers.
About Alliance Growers Corp.
Alliance Growers is a Diversified Global Medical Cannabis Company driven by the Company's 'Four Pillars' Organization Plan -
Cannabis Biotech Complex, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Technology.
Alliance Growers is working with Pharmagreen Biotech Inc. advancing a new business partnership, to jointly develop and operate a
62,000-square foot facility, to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and
Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis
Biotech Complex's main facility is the Cannabis Biotech Centre which will grow Cannabis plantlets using proprietary tissue culture
propagation, specifically utilizing the "Chibafreen Invitro Plant Production System", which allows for more tissue cultured
plantlets to be produced in less space and less time.
For further information, please visit the Company's website at www.alliancegrowers.com or the Company's profile at www.sedar.com.
If you would like to be added to Alliance Growers' news distribution list, please send your email address to newsletter@alliancegrowers.com.
For more information contact:
Dennis Petke
CEO, President and Director
Tel: 778-331-4266
DennisPetke@alliancegrowers.com
Rob Grace
Communications Consultant
Tel: 778-998-5431
RobDGrace@gmail.com
FOLLOW US:
Facebook
Twitter
LinkedIn
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF
THIS RELEASE
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable
securities laws. These statements relate to future events or future performance. All statements other than statements of historical
fact may be forward-looking statements or information. More particularly and without limitation, the news release contains
forward-looking statements and information relating to Company's corporate strategy. The forward-looking statements and information
are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the
Company's ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions
on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the
forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations
and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and
information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and
information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could
differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the
Company's ability to identify and complete additional suitable acquisitions to further the Company's growth as well as risks
associated with the medical marijuana industry in general, such as operational risks in development and production delays or
changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the
uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing
and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market;
ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals
and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place
undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned
that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking
is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future
events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking
statements or information contained in this news release are expressly qualified by this cautionary statement.
